Senator Kelly outlines significant effects of recent Medicaid and Social Security policy changes in Arizona, focusing on coverage loss, work requirements, and bipartisan legislative efforts.

Congresswoman Maggie Goodlander and colleagues urge CMS to halt the proposed expansion of prior authorization in Traditional Medicare, citing risks to patient care and administrative burdens.

Explore the 2026 Medicare Part D updates including premium increases, delayed enrollment penalties, and maximum out-of-pocket caps for prescription drugs, with insights into Medicare Advantage plan impacts.

CMS plans a voluntary five-year trial allowing state Medicaid and Medicare Part D plans to cover GLP-1 weight management drugs, including Ozempic and Wegovy, starting in 2026-27 amid pricing and coverage challenges.

Explore the Medicare cliff phenomenon where older adults lose Medicaid coverage at 65, leading to increased Medicare costs and coverage changes. Understand eligibility, cost differences, and programs to ease the transition.

A detailed analysis of the 2025 Medicare Trustees Report outlines financial projections and key cost drivers including Medicare Advantage's impact and reimbursement challenges.

States to apply September for $50B Rural Health Fund amid Medicare cuts; concerns over urban hospitals dual-classified as rural impacting fund allocation.

CMS's price-substitution policy has saved $76 million for Medicare by correcting drug pricing identified by the Office of Inspector General, improving cost efficiency while maintaining access.

Medicare faces evolving opportunities and challenges in covering weight loss drugs through legislation like the Treat and Reduce Obesity Act and federal demonstration projects. Drug adherence and cost-effectiveness remain key issues.

Explore the implications of proposed changes to the U.S. Preventive Services Task Force and its impact on preventive care guidelines and insurance coverage in the U.S.